Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

PURPOSE: The purpose of this study was to evaluate the safety and efficacy of low-dose-intensity bevacizumab and weekly irinotecan as salvage treatment for patients with platinum- and taxanes-resistant advanced epithelial ovarian cancer. METHODS: Fifty-two patients with platinum- and taxanes-resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Ren, Zhonghai, Xu, Shuning, Bai, Hua, Ma, Ning, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341009/
https://www.ncbi.nlm.nih.gov/pubmed/25599660
http://dx.doi.org/10.1007/s00280-015-2680-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341009/
https://www.ncbi.nlm.nih.gov/pubmed/25599660
http://dx.doi.org/10.1007/s00280-015-2680-4

Ejemplares similares